Stockscreener 앱 받기
280.38
0.47%
-1.29
전일 마감가:
$281.67
열려 있는:
$279.8
하루 거래량:
404.90K
Relative Volume:
0.23
시가총액:
$54.55B
수익:
$328.68B
순이익/손실:
$2.55B
주가수익비율:
21.51
EPS:
13.0349
순현금흐름:
$1.56B
1주 성능:
+2.29%
1개월 성능:
+8.79%
6개월 성능:
-19.97%
1년 성능:
-5.14%
1일 변동 폭
$274.71
$281.30
1주일 범위
$270.64
$284.93
52주 변동 폭
$244.82
$377.54
Cencora Inc Stock (COR) Company Profile
명칭
Cencora Inc
전화
610-727-7000
주소
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
280.37 | 54.80B | 328.68B | 2.55B | 1.56B | 13.03 |
MCK
Mckesson Corp
|
777.31 | 94.25B | 403.43B | 5.10B | 5.41B | 38.47 |
CAH
Cardinal Health Inc
|
224.74 | 52.43B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
81.62 | 9.26B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.252 | 1.15B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-29 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-06-03 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | 재개 | Mizuho | Outperform |
| 2024-09-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-14 | 개시 | Wells Fargo | Equal Weight |
| 2023-03-31 | 개시 | Citigroup | Buy |
| 2023-01-31 | 재개 | Evercore ISI | Outperform |
| 2022-10-11 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-08-22 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-07-11 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-06-07 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-05-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-04-12 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2021-03-12 | 재개 | Evercore ISI | In-line |
| 2021-02-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-02-02 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-01-06 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-01-06 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | 개시 | Mizuho | Neutral |
| 2020-08-06 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | 개시 | Barclays | Underweight |
| 2020-06-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | 재개 | Credit Suisse | Outperform |
| 2020-04-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-03-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-02-11 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-07-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | 개시 | Guggenheim | Buy |
| 2019-04-10 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-02-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2019-01-17 | 개시 | UBS | Buy |
| 2018-12-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2018-10-26 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | 개시 | Berenberg | Buy |
| 2018-07-17 | 재개 | Stifel | Hold |
| 2018-04-09 | 개시 | MoffettNathanson | Buy |
| 2018-03-12 | 업그레이드 | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | 개시 | JP Morgan | Neutral |
| 2017-09-22 | 개시 | William Blair | Outperform |
모두보기
Cencora Inc 주식(COR)의 최신 뉴스
Cencora Inc. Stock (US15135B1017): Valuation metrics in focus after steady share price climb - AD HOC NEWS
Is Cencora stock underperforming the Nasdaq? - MSN
Cencora Inc Stock (US03073E1055): Analyst Rating In Focus After Barclays Cuts Target - AD HOC NEWS
The Profit Margin Climb Cencora Stock Bears Keep Missing - Trefis
Cencora Drug Distribution Story Gains Healthcare Market Attention - Kalkine Media
Cencora Kite Deal Highlights CAR T Growth And Undervalued Share Price Potential - Yahoo Finance
Barclays Cuts Cencora Price Target to $350 From $425, Maintains Overweight Rating - marketscreener.com
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Central Garden & Pet stock (US15135B1017): earnings momentum and pet-care demand in focus - AD HOC NEWS
What Cencora (COR)'s Expanded Role in Kite CAR T Distribution Means For Shareholders - simplywall.st
Cencora hits 52-week low after guidance cut - MSN
Is Cencora Stock Underperforming the Nasdaq? - Barchart.com
Cencora, Inc. (COR) Stock Analysis: Strong Buy Ratings and 29.74% Potential Upside Spark Investor Interest - DirectorsTalk Interviews
A Look At Cencora (COR) Valuation After 2026 Guidance Update And New CAR T Distribution Deal - simplywall.st
Cencora shares fall 2% on second quarter earnings miss - Investing.com
Deals tracker: Tennessee senior care operator spends $50M for 5 facilities - Modern Healthcare
Cencora's Specialty Supply Chain: Where COR's Growth Is Headed - Yahoo Finance
Cencora (COR) Up 5.7% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Wall Street Analysts Predict a 33.55% Upside in Cencora (COR): Here's What You Should Know - Yahoo Finance
Cencora Q2 FY2026 slides: strategic moves amid revenue miss - Investing.com
Earnings Flash (COR) Cencora, Inc. Reports Q2 Revenue $78.36B, vs. FactSet Est of $81.09B - marketscreener.com
Earnings Flash (COR) Cencora, Inc. Posts Q2 Adjusted EPS $4.75 per Share, vs. FactSet Est of $4.82 - marketscreener.com
Cencora shares fall 2% on second quarter earnings miss By Investing.com - Investing.com Nigeria
Cencora cuts revenue growth forecast on slower US sales - marketscreener.com
Earnings call transcript: Cencora Inc. Q2 2026 misses estimates, stock drops - Investing.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc.COR - PR Newswire
WCG Wealth Advisors LLC Purchases New Position in Cencora, Inc. $COR - MarketBeat
Cencora Inc. stock (US15135B1017): shares steady as guidance raised and buyback expanded - AD HOC NEWS
Cencora shareholders elect directors and approve key proposals at annual meeting - Investing.com
Cencora (COR) Has a Specialty-Distribution Moat That Looks Stronger Than Its Thin Margins Suggest - AlphaStreet
Cencora Inc. stock (US15135B1017): new Kite CAR T-cell distribution deal highlights specialty focus - AD HOC NEWS
Cencora-Kite Agreement Signals CGT Commercialization Shift - Pharmaceutical Commerce
Cencora Inc stock (US03073E1055): shares steady ahead of next earnings after recent legal headlines - AD HOC NEWS
Billions spent, a new CFO, and a bold vision: Cencora is transforming healthcare from Conshohocken - MSN
Is Cencora’s New CFO, $2 Billion Buyback, and Lawsuit Trio Altering The Investment Case For Cencora (COR)? - Yahoo Finance
Cencora Inc. stock outperforms competitors despite losses on the day - MarketWatch
Cencora Inc. stock (US15135B1017): shares ease while investors digest new corporate responsibility r - AD HOC NEWS
Cencora, Inc. (COR) Stock Analysis: Evaluating a 32% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Cencora Inc. stock (US15135B1017): steady trading as NYSE healthcare distributor holds fiscal 2026 E - AD HOC NEWS
Insider Spends US$1.1m Buying More Shares In Cencora - simplywall.st
Cencora Appoints Eva Boratto as CFO and Reaffirms 2026 Financial Guidance - Minichart
Cencora appoints Eva Boratto as CFO, reaffirms guidance - MSN
Cencora Inc. stock (US15135B1017): new CFO appointment and 2026 EPS guidance reaffirmed - AD HOC NEWS
Assessing Cencora (COR) Valuation After Recent Share Price Weakness And Long Term Gains - simplywall.st
Cencora, Inc. (COR) Appoints New CFO and Reaffirms Financial Gui - GuruFocus
Eva C. Boratto named Cencora Executive VP & CFO as James F. Cleary to retire - TradingView
Cencora (NYSE: COR) hires new CFO Eva Boratto and reaffirms 2026 and long-term EPS targets - Stock Titan
Insider Buying: Dermot Durcan Acquires Shares of Cencora Inc (CO - GuruFocus
Cencora director D. Mark Durcan buys $1.07m in stock By Investing.com - Investing.com Canada
Cencora director D. Mark Durcan buys $1.07m in stock - Investing.com
Cencora Inc (COR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.41%
0.73%
자본화:
|
볼륨(24시간):